CSIMarket
 


Myokardia Inc   (MYOK)
Other Ticker:  
 
 

MYOK's EPS from Cont. Operations Growth by Quarter and Year

Myokardia Inc 's EPS from Cont. Operations results by quarter and year




MYOK EPS from Cont. Operations (in $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -1.27 -0.45 -0.21
III Quarter September -1.60 -3.07 -0.39 -0.42
II Quarter June -1.27 -0.83 -0.49 -0.41
I Quarter March -1.50 -0.93 -0.50 -0.37
FY   -4.37 -6.10 -1.83 -1.41



MYOK EPS from Cont. Operations third quarter 2020 Y/Y Growth Comment
Myokardia Inc in the third quarter 2020 recorded EPS loss from Cont. Operations of $ -1.60 .

According to the results reported in the third quarter 2020, Myokardia Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Myokardia Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2020.




MYOK EPS from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Myokardia Inc 's third quarter 2020 EPS from Cont. Operations $ -1.60 MYOK's Income Statement
Myokardia Inc 's third quarter 2019 EPS from Cont. Operations $ -3.07 Quarterly MYOK's Income Statement
New: More MYOK's historic EPS from Cont. Operations Growth >>


MYOK EPS from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Myokardia Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MYOK's III. Quarter Q/Q EPS from Cont. Operations Comment
Current accomplishment of -1.60 by Myokardia Inc look even more unfavourable if you take a look at EPS loss from Cont. Operations -1.27 in the second quarter.

Within Major Pharmaceutical Preparations industry Myokardia Inc achieved highest sequential EPS from Cont. Operations growth. While Myokardia Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MYOK's III. Quarter Q/Q EPS from Cont. Operations Comment
Current results of -1.60 by Myokardia Inc look even more unfavourable if you take a look at -1.27 in the previous quarter.

Within Major Pharmaceutical Preparations industry Myokardia Inc achieved highest sequential EPS from Cont. Operations growth. While Myokardia Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Myokardia Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative EPS from Cont. Operations 12 Months Ending $ -5.64 $ -7.11 $ -6.67 $ -6.10 $ -5.28
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Myokardia Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -6 in the Sep 30 2020 period.

Myokardia Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Myokardia Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -6 in the Sep 30 2020 period.

Myokardia Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
MYOK's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for MYOK's Competitors
EPS from Cont. Operations Growth for Myokardia Inc 's Suppliers
EPS from Cont. Operations Growth for MYOK's Customers

You may also want to know
MYOK's Annual Growth Rates MYOK's Profitability Ratios MYOK's Asset Turnover Ratio MYOK's Dividend Growth
MYOK's Roe MYOK's Valuation Ratios MYOK's Financial Strength Ratios MYOK's Dividend Payout Ratio
MYOK's Roa MYOK's Inventory Turnover Ratio MYOK's Growth Rates MYOK's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2020
Masimo Corp-2.17%$ -2.174 
Orgenesis Inc -2.27%$ -2.273 
Mylan N v -2.70%$ -2.703 
Baxter International Inc -2.78%$ -2.778 
Eli Lilly And Company-2.92%$ -2.920 
Conmed Corporation-4.00%$ -4.000 
U S Physical Therapy Inc-7.58%$ -7.576 
Tactile Systems Technology Inc -7.69%$ -7.692 
Icu Medical Inc-7.75%$ -7.752 
Emergent Biosolutions Inc -10.71%$ -10.714 
3m Company-10.91%$ -10.909 
Viemed Healthcare Inc -12.50%$ -12.500 
Bruker Corporation-12.50%$ -12.500 
Acadia Healthcare Company Inc -14.29%$ -14.286 
China Health Industries Holdings Inc -14.78%$ -14.783 
Biospecifics Technologies Corp-15.12%$ -15.116 
Heartbeam Inc -16.67%$ -16.667 
Becton Dickinson And Company-16.98%$ -16.981 
Corcept Therapeutics Inc-17.39%$ -17.391 
Utah Medical Products Inc-19.00%$ -19.000 
Encompass Health Corporation-21.21%$ -21.212 
Intuitive Surgical Inc -22.09%$ -22.093 
Carlisle Companies Incorporated-23.27%$ -23.265 
Illumina Inc -23.27%$ -23.270 
Atrion Corporation-23.40%$ -23.404 
Innoviva Inc -28.21%$ -28.205 
Zynex inc -33.33%$ -33.333 
National Healthcare Corp-33.86%$ -33.858 
Msa Safety Incorporated-33.94%$ -33.945 
Dentsply Sirona Inc -34.21%$ -34.211 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com